Retina-Vitreous
2024 , Vol 33 , Num 4
Comprasion of aflibersept and ranibizumab response in patients with DMO unresponsive to bevacizumab treatment: early versus late switch
1Ophtalmology, Prof Dr Cemil Tascioglu City Hospital, İstanbul, Türkiye2Endocrinology and Internal Medicine, Prof. Dr. Cemil Tascioglu City Hospital, İstanbul, Türkiye DOI : 10.37845/ret.vit.2024.33.37 Keywords :